DE60232797D1 - Histon deazetylase enzym-hemmende hydroxamsäurederivate als neue entzündungshemmer zur hemmung der zytokinsynthese - Google Patents
Histon deazetylase enzym-hemmende hydroxamsäurederivate als neue entzündungshemmer zur hemmung der zytokinsyntheseInfo
- Publication number
- DE60232797D1 DE60232797D1 DE60232797T DE60232797T DE60232797D1 DE 60232797 D1 DE60232797 D1 DE 60232797D1 DE 60232797 T DE60232797 T DE 60232797T DE 60232797 T DE60232797 T DE 60232797T DE 60232797 D1 DE60232797 D1 DE 60232797D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibiting
- enzyme
- deazetylase
- cytokin
- histon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI001733A ITMI20011733A1 (it) | 2001-08-07 | 2001-08-07 | Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc |
PCT/EP2002/008379 WO2003013493A1 (en) | 2001-08-07 | 2002-07-26 | Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60232797D1 true DE60232797D1 (de) | 2009-08-13 |
Family
ID=11448251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60232797T Expired - Lifetime DE60232797D1 (de) | 2001-08-07 | 2002-07-26 | Histon deazetylase enzym-hemmende hydroxamsäurederivate als neue entzündungshemmer zur hemmung der zytokinsynthese |
Country Status (23)
Country | Link |
---|---|
US (1) | US20040157930A1 (de) |
EP (1) | EP1414428B1 (de) |
JP (1) | JP2005506320A (de) |
KR (1) | KR20040035724A (de) |
CN (1) | CN1538838A (de) |
AT (1) | ATE435013T1 (de) |
BR (1) | BR0212014A (de) |
CA (1) | CA2456533A1 (de) |
CY (1) | CY1109391T1 (de) |
DE (1) | DE60232797D1 (de) |
DK (1) | DK1414428T3 (de) |
ES (1) | ES2328468T3 (de) |
HU (1) | HUP0401167A2 (de) |
IL (1) | IL160075A0 (de) |
IS (1) | IS7124A (de) |
IT (1) | ITMI20011733A1 (de) |
MX (1) | MXPA04001190A (de) |
NO (1) | NO20040513L (de) |
PL (1) | PL365391A1 (de) |
PT (1) | PT1414428E (de) |
RU (1) | RU2004106605A (de) |
SI (1) | SI1414428T1 (de) |
WO (1) | WO2003013493A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
JP2005525345A (ja) * | 2002-02-15 | 2005-08-25 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | Trx媒介性疾患を処置する方法 |
AU2003211362A1 (en) * | 2002-02-21 | 2003-09-09 | Osaka Industrial Promotion Organization | N-hydroxycarboxamide derivative |
US7456219B2 (en) | 2002-03-04 | 2008-11-25 | Merck Hdac Research, Llc | Polymorphs of suberoylanilide hydroxamic acid |
AU2003213684C1 (en) | 2002-03-04 | 2008-10-23 | Merck Hdac Research, Llc | Methods of inducing terminal differentiation |
AU2003243272A1 (en) | 2002-05-22 | 2003-12-12 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
AU2003291097A1 (en) * | 2002-11-20 | 2004-06-15 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
ITMI20030025A1 (it) | 2003-01-10 | 2004-07-11 | Italfarmaco Spa | Derivati dell'acido idrossammico ad attivita' antinfiammatoria. |
ITMI20030064A1 (it) | 2003-01-17 | 2004-07-18 | Italfarmaco Spa | Uso dei derivati dell'acido idrossamico per la preparazione |
ES2328819T3 (es) | 2003-04-07 | 2009-11-18 | Pharmacyclics, Inc. | Hidroxamatos como agentes terapeuticos. |
EP1491188A1 (de) * | 2003-06-25 | 2004-12-29 | G2M Cancer Drugs AG | Topische Verwendung von Valproinsäure zur Behandlung von Hauterkrankungen |
EP1663194B1 (de) * | 2003-08-26 | 2010-03-31 | Merck HDAC Research, LLC | Verwendung von SAHA zur Behandlung von Mesotheliom |
CA2552279C (en) | 2003-12-02 | 2014-07-15 | The Ohio State University Research Foundation | Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors |
GB2427405A (en) * | 2004-04-07 | 2006-12-27 | Pharmacyclics Inc | Novel hydroxamates as therapeutic agents |
AU2005271841A1 (en) * | 2004-07-12 | 2006-02-16 | Merck & Co., Inc. | Inhibitors of histone deacetylase |
GB2417682A (en) * | 2004-08-18 | 2006-03-08 | Univ East Anglia | Histone deacetylse inhibitor for treating connective tissue disorders |
US7732475B2 (en) | 2005-07-14 | 2010-06-08 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
WO2007109178A2 (en) | 2006-03-16 | 2007-09-27 | Pharmacyclics, Inc. | Indole derivatives as inhibitors of histone deacetylase |
WO2008061160A1 (en) * | 2006-11-14 | 2008-05-22 | Pharmacyclics, Inc. | Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
WO2008060721A1 (en) * | 2006-11-14 | 2008-05-22 | Pharmacyclics, Inc. | Uses of selective inhibitors of hdac8 for treatment of t-cell proliferative disorders |
AU2007340129B2 (en) * | 2006-12-26 | 2012-02-02 | Pharmacyclics Llc | Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
KR101483805B1 (ko) | 2007-01-30 | 2015-01-16 | 파마시클릭스, 인코포레이티드 | 히스톤 데아세틸라제 억제제에 대한 암 내성을 확인하는 방법 |
US9827212B2 (en) * | 2009-03-18 | 2017-11-28 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating asthma and other lung diseases |
US8603521B2 (en) | 2009-04-17 | 2013-12-10 | Pharmacyclics, Inc. | Formulations of histone deacetylase inhibitor and uses thereof |
CA2770158A1 (en) * | 2009-08-14 | 2011-02-17 | Cellzome Ag | Methods for the identification and characterization of hdac interacting compounds |
WO2012018499A2 (en) * | 2010-08-05 | 2012-02-09 | Acetylon Pharmaceuticals | Specific regulation of cytokine levels by hdac6 inhibitors |
CA2866333C (en) * | 2011-03-09 | 2020-12-29 | Cereno Scientific Ab | Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors |
ES2627820T3 (es) | 2011-09-13 | 2017-07-31 | Pharmacyclics, Inc. | Formulaciones de inhibidor de histona desacetilasa en combinación con bendamustina y usos de las mismas |
EP3871669A1 (de) * | 2012-02-03 | 2021-09-01 | Italfarmaco SpA | Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalin-2-yl-methyl]-ammoniumchlorid zur verwendung bei der behandlung von muskeldystrophie |
CN102793693A (zh) * | 2012-09-07 | 2012-11-28 | 天津医科大学 | 伏立诺他在制备治疗自身免疫及炎症性疾病药物方面的应用 |
GB201417828D0 (en) | 2014-10-08 | 2014-11-19 | Cereno Scient Ab | New methods and compositions |
EP3439649B1 (de) | 2016-04-08 | 2023-11-15 | Cereno Scientific AB | Pharmazeutische formulierungen mit verzögerter freisetzung mit valproinsäure und verwendungen davon |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5700811A (en) | 1991-10-04 | 1997-12-23 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and method of use thereof |
US5318964A (en) * | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
EP0757984B1 (de) * | 1995-08-08 | 2002-10-30 | Ono Pharmaceutical Co., Ltd. | Hydroxamsäurederivate verwendbar zur Hemmung von Gelatinase |
US6777217B1 (en) * | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
IT1283637B1 (it) * | 1996-05-14 | 1998-04-23 | Italfarmaco Spa | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
WO2002055017A2 (en) * | 2000-11-21 | 2002-07-18 | Wake Forest University | Method of treating autoimmune diseases |
-
2001
- 2001-08-07 IT IT2001MI001733A patent/ITMI20011733A1/it unknown
-
2002
- 2002-07-26 DE DE60232797T patent/DE60232797D1/de not_active Expired - Lifetime
- 2002-07-26 PT PT02764796T patent/PT1414428E/pt unknown
- 2002-07-26 BR BR0212014-3A patent/BR0212014A/pt not_active IP Right Cessation
- 2002-07-26 PL PL02365391A patent/PL365391A1/xx not_active Application Discontinuation
- 2002-07-26 WO PCT/EP2002/008379 patent/WO2003013493A1/en active Application Filing
- 2002-07-26 DK DK02764796T patent/DK1414428T3/da active
- 2002-07-26 IL IL16007502A patent/IL160075A0/xx unknown
- 2002-07-26 MX MXPA04001190A patent/MXPA04001190A/es unknown
- 2002-07-26 EP EP02764796A patent/EP1414428B1/de not_active Expired - Lifetime
- 2002-07-26 HU HU0401167A patent/HUP0401167A2/hu unknown
- 2002-07-26 CA CA002456533A patent/CA2456533A1/en not_active Abandoned
- 2002-07-26 SI SI200230840T patent/SI1414428T1/sl unknown
- 2002-07-26 RU RU2004106605/15A patent/RU2004106605A/ru not_active Application Discontinuation
- 2002-07-26 KR KR10-2004-7001946A patent/KR20040035724A/ko not_active Application Discontinuation
- 2002-07-26 JP JP2003518503A patent/JP2005506320A/ja active Pending
- 2002-07-26 US US10/486,152 patent/US20040157930A1/en not_active Abandoned
- 2002-07-26 AT AT02764796T patent/ATE435013T1/de active
- 2002-07-26 ES ES02764796T patent/ES2328468T3/es not_active Expired - Lifetime
- 2002-07-26 CN CNA028154363A patent/CN1538838A/zh active Pending
-
2004
- 2004-01-26 IS IS7124A patent/IS7124A/is unknown
- 2004-01-29 NO NO20040513A patent/NO20040513L/no unknown
-
2009
- 2009-09-21 CY CY20091100978T patent/CY1109391T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20040157930A1 (en) | 2004-08-12 |
IL160075A0 (en) | 2004-06-20 |
PT1414428E (pt) | 2009-08-25 |
ES2328468T3 (es) | 2009-11-13 |
WO2003013493A8 (en) | 2004-02-26 |
EP1414428B1 (de) | 2009-07-01 |
DK1414428T3 (da) | 2009-08-31 |
SI1414428T1 (sl) | 2009-10-31 |
KR20040035724A (ko) | 2004-04-29 |
HUP0401167A2 (hu) | 2004-11-29 |
IS7124A (is) | 2004-01-26 |
CY1109391T1 (el) | 2014-07-02 |
CA2456533A1 (en) | 2003-02-20 |
MXPA04001190A (es) | 2005-02-17 |
JP2005506320A (ja) | 2005-03-03 |
EP1414428A1 (de) | 2004-05-06 |
ITMI20011733A1 (it) | 2003-02-07 |
ATE435013T1 (de) | 2009-07-15 |
WO2003013493A1 (en) | 2003-02-20 |
PL365391A1 (en) | 2005-01-10 |
CN1538838A (zh) | 2004-10-20 |
RU2004106605A (ru) | 2005-05-10 |
ITMI20011733A0 (it) | 2001-08-07 |
BR0212014A (pt) | 2004-08-03 |
NO20040513L (no) | 2004-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60232797D1 (de) | Histon deazetylase enzym-hemmende hydroxamsäurederivate als neue entzündungshemmer zur hemmung der zytokinsynthese | |
ATE396971T1 (de) | Sulfonylaminoderivate als neue inhibitoren von histondeacetylase | |
BR0206738A (pt) | Derivados tricìclicos de lactama e de sultama e uso dos mesmos como inibidores de histona desacetilase | |
NO20044557L (no) | Inhibitorer av histon deacetylase | |
BRPI0409227B8 (pt) | "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)" | |
ES2196917T3 (es) | Amidas heteroaromaticas como inhibidores del factor xa`. | |
BRPI0518467A2 (pt) | derivado de Ácido antranÍlico, inibidor de produÇço de metaloprotease de matriz 13, e, agente terapÊutico para artrite reumatàide | |
DE60321775D1 (de) | Carbaminsäurederivate enthaltend eine piperazin verknüpfung als hdac-inhibitoren | |
EA200401199A1 (ru) | Ингибиторы гистондеацетилазы | |
DE60321548D1 (de) | Carbonylamino- derivativate als neue inhibitoren von histone deacetylase | |
BRPI0410727A (pt) | composto, composição farmacêutica, e, uso de um composto | |
BR0307575A (pt) | Derivados de sulfonila como inibidores de histona desacetilase | |
WO2002046129A3 (en) | Inhibitors of histone deacetylase | |
BRPI0508047A (pt) | derivados de alquilpiperazina-e alquil-homopiperazina-carboxilatos, o respectivo preparo e a respectiva aplicação como inibidores da enzima faah | |
DK1030836T3 (da) | Hydroxam- og carboxylsyrederivater der har MMP- og TNF-inhiberende aktivitet | |
ATE457302T1 (de) | Aromatische etherderivate als thrombin-hemmer | |
ATE280763T1 (de) | Matrix-metalloproteinase-hemmer | |
ATE252576T1 (de) | Heteroarylphenylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel | |
EA200701970A1 (ru) | Гидроксаматы как ингибиторы гистондеацетилазы и содержащие их фармацевтические композиции | |
FI980604A0 (fi) | Nya matrismetalloproteinasinhibitorer och -regulatorer | |
BR0114697A (pt) | Derivados em ponte de piperazina | |
ATE253359T1 (de) | Antithrombotische mittel | |
NO983444L (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer | |
ATE286395T1 (de) | Antithrombotische mittel | |
CO5690574A2 (es) | Nuevos compuestos derivados de indolina como inhibidores de la colesterol-actiltransferasa (acat) y uso medico del mismo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |